Refresh

Piramal Pharma Ltd. - Research Center

543635 PPLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Cash Flow
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21

Profit before tax

507.62 130.65 436.70 668.55

Net cashflow-operating activity

358.29 71.52 255.20 34.72

Net cash used in investing activity

-635.52 -435.05 -1,223.02 -4,382.89

Netcash used in fin. activity

451.38 290.12 905.74 4,494.16

Net inc/dec in cash and equivlnt

174.52 -73.41 -62.08 145.99

Cash and equivalnt begin of year

54.28 127.69 146.73 0.74

Cash and equivalnt end of year

228.80 54.28 84.65 146.73
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com